Clinical trial
Doravirine Dose Optimisation in Pregnancy
NCT05630638 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Doravirine Dose Optimisation in Pregnancy
- Lead sponsor
- University of Liverpool
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 10, 2023
- Completion date
- July 31, 2028
- Enrollment
- 76 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv